目的：探討輸卵管性不孕婦女生存質量及其影響因素，并為輸卵管性不孕癥治療決策的選擇提供相應的依據。方法：采用生存質量測評量表SF-36對80名輸卵管性不孕婦女及80名已生育或妊娠的健康婦女進行了同期的橫斷面調查與比較。結果：輸卵管性不孕婦女的生存質量較正常健康婦女人群低，除了生理功能及軀體疼痛外，輸卵管性不孕婦女有關社會功能、生理問題對功能的限制、心理問題對功能的限制、心理健康、活力、健康的總體評價、健康變化程度等七個方面的主觀滿意度均較對照組低，差異有顯著意義(Plt;0.05)。患者的年齡、文化程度及居住環境對其生存質量有影響。結論：在治療不孕癥時，不應僅針對其病因治療，而且要重視心理和社會因素的作用，加強心理治療，重視健康教育，針對性地改善患者在精神、社會、心理等方面的主觀體驗，以促進不孕癥婦女生存質量的提高。
【摘要】 目的 分析宮腔鏡聯合腹腔鏡在不孕癥診治中的應用和意義。 方法 回顧性分析2007年1月-2009年12月采用宮腔鏡聯合腹腔鏡手術診治92例女性不孕癥患者的臨床資料。 結果 92例中原發不孕39例，繼發不孕53例；其中有盆腔病變者86例，占93.5%。不孕原因居前四位分別是盆腔粘連31例（33.7%），輸卵管阻塞24例（26.1%），子宮內膜異位癥10例（10.9%），子宮內膜息肉8例（8.7%）。輸卵管阻塞24例行宮腔鏡引導下單極電凝器鈍性逆行分離術或造口術，有20例輸卵管復通，復通率66.7%。術后6~12個月年隨訪，妊娠率為19.6%（18/92），其中宮內妊娠15例，宮外孕3例。 結論 腹腔鏡聯合宮腔鏡檢查能快速準確地明確女性不孕的確切原因及部位，并可采取針對性治療措施，是目前診治不孕癥的可靠方法。【Abstract】 Objective To investigate the application and role of laparoscopy combined with hysteroscopy in the diagnosis and treatment of infertile patients. Methods Ninety-two patient with infertility who examined and treated with laparoscopy combined with hysteroscopy in this hospital were retrospectively analyzed from January 2007 to December 2009. Results There were 39 patients with primary infertility and 53 patients with secondary infertility.The main reason of infertility was pelvic diseases (93.5%). In the pelvic diseases,the common causes included pelvic adhesion (31 cases, 33.7%), obstruction of oviduct (24 cases, 26.1%), endometriosis (10 cases, 10.9%), and endometrial polyp (8 cases, 8.7%). Twenty-four patients with obstruction of oviduct were treated with hysteroscopy conducting unipolar electrocoagulation tool, 20 fallopian tubes were unobstructed. The recover rate was 66.7%. All the patients received follow-up by 6 - 12 months, and the pregnancy rate was 19.6% (18/92). Out of these 18 patients, 15 patients were intrauterine and 3 extrauterine. Conclusion Laparoscopy combined with hysteroscopy can find out the exact reasons of infertility and offer the respective treatment, and be a reliable method to diagnose and treat infertility patient.
【摘要】目的探討腹腔鏡聯合盆腔理療對輸卵管性不孕癥的治療效果,旨在提高術后的受孕率。方法將2007年1月2008年12月進行診治的不孕者86例隨機分為干預組與對照組,每組43例。干預組腹腔鏡手術治療,術后進行理療;對照組不進行理療。調查并比較兩組的治療效果和患者滿意度。結果干預組43例中13例再次宮內妊娠,受孕率為30.23%;對照組再次宮內妊娠,8例(18.60%)兩組比較差異具有統計學意義(Plt;0.05)。干預組總有效率86.05%,明顯優于對照組67.44%,且差異亦具有統計學意義(Plt;0.05)。患者滿意率干預組為90.67%(39/43),對照組為76.74%(33/43)。兩組差異具有統計學意義(Plt;0.05)。結論腹腔鏡聯合盆腔理療可以有效改善治療效果,提高再次受孕率,值得在臨床實踐中推廣應用。
目的:比較不同麻醉方法在腹腔鏡婦科不孕檢查及治療術中的效果和安全性。方法:選擇不孕擬在腹腔鏡下行檢查及治療術的患者60例,隨機分為三組,每組20人,分別進行連續硬膜外麻醉(簡稱EA組);靜吸復合全身麻醉(簡稱GA組);連續硬膜外麻醉加靜吸復合全身麻醉(簡稱EGA組),觀察比較三種麻醉方法對患者呼吸,循環及麻醉效果的影響。結果:三種麻醉方法均可保證手術完成,EA組術中管理較為麻煩,GA組循環波動大,EGA組麻醉效果更好,各種藥物用量減少,患者血液動力學更穩定,恢復快,管理更輕松。結論:連續硬膜外麻醉加靜吸復合全身麻醉(EGA)可避免其它兩種麻醉方式不足,各取長處,更適用于腹腔鏡婦科不孕檢查及治療術麻醉。
【摘要】 目的 探討絕經期促性腺激素及氯米芬在促排卵治療中適宜的治療方法。 方法 2004年8月〖CD3/5〗2008年5月對80例不孕患者實施促排卵治療。測定血雌激素、黃體生成素水平、陰道B型超聲、子宮頸黏液評分及基礎體溫測定監測排卵,并觀察不良反應的發生情況。 結果 使用氯米芬及絕經期促性腺激素排卵率分別為773%和856%；卵巢過度刺激綜合癥發生率為150%,大多由使用絕經期促性腺激素方案引起,且起始劑量150 U；未破裂卵泡黃素化綜合征的發生率為90%。 結論 絕經期促性腺激素和氯米芬治療排卵障礙性不孕有較好的療效,絕經期促性腺激素和氯米芬促排卵治療效果與卵巢的狀態及激素水平有關。促性腺激素的使用應強調個體化,以達到較好的治療效果并降低卵巢過度刺激綜合癥的發生。【Abstract】 Objective To explore the proper method with human menopausal gonadotropin and clomiphene in facilitating ovulation treatment. Methods Eighty infertility patients with the facilitating ovulation treatment were included from August 2004 to May 2008. Ovulation monitoring was based on the level of estrogen and luteinizing hormone, transvaginal B ultrasound, the cervical Inlser score and assay of basal body temperature. Besides, adverse reactions were observed. Results The rates of ovulation of clomiphene and human menopausal gonadotropin were 77.3% and 85.6%. The rate of ovarian hyperstimulation syndrome (OHSS), which was mostly caused by human menopausal gonadotropin with 150 IU, was 150%. The rate of luteinized unruptured follicle syndrome (LUFS) was 90%. Conclusion Individual therapy with human menopausal gonadotropin and clomiphene is essential to infertility patients with ovulation barrier. The efficacy of human menopausal gonadotropin and clomiphene is relevant to the ovarian condition and the hormone levels. Individual using of hormone is important in the facilitating ovulation treatment, which is helpful to increase the effective efficacy and prevent the OHSS.
Objective To assess the effectiveness and safety of traditional Chinese medicinal herbs for subfertility. Method Databases used including MEDLINE, EMBASE, CBM and the Cochrane Controlled Trial Register (CCTR). Potentially related trials in reference lists of studies were hand searched. Published RCTs in any languages and length whether they were blind or unblind, were included. Treatments were Chinese medicinal herbs (single or compound), and controls were placebo, standard medical intervention, or no intervention. Data were extracted independently by two reviewers and analyzed with Revman 4.2 softeware. Results 7 randomized trials, including 1 042 patients met inclusion criteria. Methodological quality of all trials was poor. Chinese medicinal herbs were effective compared with routine antibiotics [RR 1.49, 95％CI (1.37 to1.62), Plt;0.000 01] and resulted in higher pregnancy rate [RR 1.46, 95%CI (1.09 to,1.96), P=0.01]. There were no adverse events reported in treatment group. Conclusions Some Chinese medicinal herbs may be effective for subfertility. However, the evidence is too weak to draw a conclusion. More strictly designed, randomized, double-blind, placebo-controlled trials are required.
ObjectiveTo investigate the effect of laparoscopic surgery combined with the following treatment of gonadotropin-releasing hormone agonist (GnRH-a) on the patients with endometriotic infertility and the value of endometriosis fertility index (EFI) system on forecasting the pregnancy outcome. MethodsFrom January 2005 to July 2011, the clinical data of 15 patients with endometriotic infertility patients were analyzed retrospectively. All the patients underwent laparoscopic surgery, and the effect was evaluated according to the endometriosis fertility index (EFI). Then all the patients were divided randomly into two groups on the basis of the different assisted treatment after the laparoscopic surgery:the control group (without any other therapy) and the GnRh-a group (combined with GnRH-a). Eventually, the pregnant rates were calculated respectively in the different groups or according to the different EFI. ResultsAt last, 103 cases finished the follow-up. The pregnancy rate in the control group after 6 months, 1 year and 3 years therapy were 12.5%, 31.2%, and 41.7%, respectively; while in the GnRh-a group were 0%, 16.3%, and 40.0%, respectively. There were no difference between the two groups after the 1 year and 3 years therapy (P>0.05). Besides, all of the 55 cases in the GnRh-a group had side-effects, but no severe adverse effect was encountered. All the side-effects were disappeared after stopping the treatment. The pregnancy rate of the patients with the EFI score of 8-10 was respectively 31.3% 1 year and 62.5% 3 years after the treatment. However, the pregnancy rate of the patients with the EFI score of 5-7 was respectively 15.2% 1 year and 26.0% 3 years after the treatment. There were only 9 patients with the EFI score of 0-4, and all of them were not pregnant. The EFI score had positive correlation with the pregnancy rate 1 year and 3 years after the treatment (rs=0.204, P=0.039; rs=0.437, P<0.001). ConclusionThe treatment of GnRh-a after the laparoscopic surgery can not only increase the rate of the pregnancy, but also delay the pregnancy occasion and increase the occurrence of the side-effects. The EFI may be valuable for forecasting the rate of pregnancy in patients with endometriotic infertility. The patients with EFI score higher than 8 may expect the pregnancy, while the ones with below 7 probably have much lower rate of natural pregnancy rate.
Objective To assess the effectiveness and safety of Chinese medicinal herbs for female immune-caused subfertility. Methods Databases included: MEDLINE (1966-2002.2), EMBASE (1984-2002.2), CBM (1978-2002.2) and Cochrane Controlled Trial Register, CCTR (Issue 1, 2002). Reference lists of trials were handsearched. Published randomized controlled trials (RCTs) whether blind or unblind, any languages and length of follow up were included. Treatments included Chinese medicinal herbs (single or compound). Controls were placebo and western medicine, or no intervention. Data were extracted independently by two reviewers and analyzed with Revman 4.2. Results Six RCTs were included, all of which were poor in methodological quality. Because of different therapies in the treatment and control groups, we did not perform meta-analysis. The No.1 anti-immune tablet was more effective than corticosteroid plus condom during intercourse both in the pregnancy rate (RR 3.75, 95%CI 1.61 to 8.75, P=0.002) and AsAb negative rate (RR 1.66, 95%CI 1.23 to 2.22, P=0.000 8). Bushen Xiezhuo Soup was more effective than antibiotic in the pregnancy rate (RR 2.97, 95%CI 1.60 to 5.50, P=0.000 6) and antisperm antibody (AsAb) negative rate (RR 2.33, 95%CI 1.54 to 3.54, Plt;0.000 1)。Zhenqi Zhuanyin Soup was as effective as IUI in pregnancy rate (RR 1.80, 95%CI 0.58 to 5.60, P＝0.31) but more effective than IUI in AsAb negative conversion rate (RR 9.61, 95%CI 3.22 to 28.67, Plt;0.000 1), Zhenqi Zhuanyin Soup combined with IUI was more effective than IUI in pregnancy rate (RR 3.60, 95%CI 1.32 to 9.85,P=0.01) and AsAb negative rate (RR 8.92, 95%CI 2.98 to 26.75, Plt;0.000 1). Conclusions Some Chinese medicinal herbs may work well in subfertility treatment. However, the evidence is too weak to draw a conclusion for there are deficiencies in strict randomization, blinding and follow-up.More strictly designed, randomized, double-blind, placebo-controlled trials are required.